Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-08-26

FDA Approved: NITISINONE — Original Application (Endo USA, Inc.)

View source ↗

Summary

FDA approved an original application for nitisinone (Endo USA, Inc.), a generic version of nitisinone for hereditary tyrosinemia type I.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nitisinone (Nitisinone)

Snippet

ORIG AP for NITISINONE (NITISINONE)